The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Gene expression profiling (GEP) to predict the primary site of metastatic neuroendocrine tumors (NETs) presenting with an unknown primary.
Eugene Woltering
No relevant relationships to disclose
Lowell Brian Anthony
Consultant or Advisory Role - bioTheranostics
Anne E. Diebold
No relevant relationships to disclose
J Philip Boudreaux
No relevant relationships to disclose
Yi-Zarn Wang
No relevant relationships to disclose